Su George, Hodnett Maki, Wu Nanyan, Atakilit Amha, Kosinski Cynthia, Godzich Mika, Huang Xiao Zhu, Kim Jiyeun K, Frank James A, Matthay Michael A, Sheppard Dean, Pittet Jean-François
Lung Biology Center, Division of Pulmonary and Critical Care Medicine, Laboratory of Surgical Research, Department of Anesthesia, and Cardiovascular Research Institute, University of California, San Francisco, California 94158, USA.
Am J Respir Cell Mol Biol. 2007 Mar;36(3):377-86. doi: 10.1165/rcmb.2006-0238OC. Epub 2006 Nov 1.
Increased lung vascular permeability is an important contributor to respiratory failure in acute lung injury (ALI). We found that a function-blocking antibody against the integrin alphavbeta5 prevented development of lung vascular permeability in two different models of ALI: ischemia-reperfusion in rats (mediated by vascular endothelial growth factor [VEGF]) and ventilation-induced lung injury (VILI) in mice (mediated, at least in part, by transforming growth factor-beta [TGF-beta]). Knockout mice homozygous for a null mutation of the integrin beta5 subunit were also protected from lung vascular permeability in VILI. In pulmonary endothelial cells, both the genetic absence and blocking of alphavbeta5 prevented increases in monolayer permeability induced by VEGF, TGF-beta, and thrombin. Furthermore, actin stress fiber formation induced by each of these agonists was attenuated by blocking alphavbeta5, suggesting that alphavbeta5 regulates induced pulmonary endothelial permeability by facilitating interactions with the actin cytoskeleton. These results identify integrin alphavbeta5 as a central regulator of increased pulmonary vascular permeability and a potentially attractive therapeutic target in ALI.
肺血管通透性增加是急性肺损伤(ALI)导致呼吸衰竭的重要因素。我们发现,一种针对整合素αvβ5的功能阻断抗体可在两种不同的ALI模型中防止肺血管通透性的发展:大鼠的缺血再灌注(由血管内皮生长因子[VEGF]介导)和小鼠的通气诱导性肺损伤(VILI,至少部分由转化生长因子-β[TGF-β]介导)。整合素β5亚基纯合缺失突变的基因敲除小鼠在VILI中也能免受肺血管通透性增加的影响。在肺内皮细胞中,αvβ5基因缺失和阻断均能防止VEGF、TGF-β和凝血酶诱导的单层通透性增加。此外,通过阻断αvβ5可减弱这些激动剂各自诱导的肌动蛋白应力纤维形成,这表明αvβ5通过促进与肌动蛋白细胞骨架的相互作用来调节诱导的肺内皮通透性。这些结果表明整合素αvβ5是肺血管通透性增加的核心调节因子,也是ALI中一个潜在的有吸引力的治疗靶点。